Member Info for LiquidSilver

Payment was made in October…basically we are close to breakeven! 4.5p is a great price to buy…company is stable, revenue generative and growing on the £3m….when the RNS is announced stating officially cash flow positive the price won’t be in the 4-5p range in my opinion.

Specific questions for the board please.

There are too many back and forth personal comments between posters to get serious analysis.

Can you summarize or better still give a detailed analysis why it is high risk at 3.5-4p or even overvalued?

Thank you

Gold assays due this week? 5,000m drilling.

Looks a squeeze from 3p with limited traders/flippers stock available and investors buying before January Rare Earths assays - a-lot of news-flow over the coming 3-4 weeks and leveraged traders will probably start buying before results

https://youtu.be/BzaJo7feTc8

Good watch and passionate CEO with owning stock. Looks like someone to support and will be successful. No
Risk of dilution under 5p I’d suggest and probably higher.

I see a lot of posts on here backwards and forwards with limited sense to the company and whether they have stability, growth and whether it’s a good level to invest.

I and a few others are looking to buy and would appreciate an understanding why it’s a good price to buy in or not (dsaf).

Watched the results from 3 weeks ago: https://youtu.be/LOXx7J9ct7Y

Jag Grewal comments:

‘Sit now in a very exciting position…We are a cash generative profitable business with very big growth potential’

Margin over 65% for September, backlog of orders and Chinese order in December £650k

Asking a broker this week their comment was….’with the company going on record to advise they have £6.5m cash on the balance sheet I would suggest they are funded and no need for a capital raise so 3.4-4p is a good level to build a position’.

£6.5m cash in the bank
Market cap £8/9m

Can posters advise specific reasons why Omega Diagnostics are not a buy at this level below 4p and the ones that do can you advise what’s holding you back from buying below 4p?

Last time the price was 0.3 it ran to 1.2p….if you are a new shareholder at 0.3 he may just deliver nicely - buy when the market panics and people are emotional…makes sense at this price even to understandable negative posters I’m sure!

GL

How much stock has now been raised over the last few months at 0.4 and how much of that stock will be sold to keep the warrants at 0.5 in a weak market?

Need an exit price...Possible trade between 0.21-0.35 if news comes but risky GL.

IF they use these funds to repay debt, how much debt remains and at what terms and what are the dates?

Dr Chris Hand, Non-Executive Chairman of Abingdon Health plc, commented: "......now returning to growth.....

"I would like to thank colleagues, friends, customers and shareholders for their support as we move to the next phase of our Company's growth with continued confidence."

Is Panther a buy at 5p and are you looking for a certain buy-in price?

I note the board of Abingdon own 17% of the company, Its in the interest of the board for the company to grow and be a turn around from 4p?

Chris Hand 13,028,467 10.70%
Chris Yates 7,888,844 6.48%

There is another 30% of the company within these company hands...Can more knowledgeable people advise who they are? Are they tight and if so any significant news means nearly 50% tied up and a potential squeeze higher...I noticed how quickly the price moved to 10p on the October RNS....

Enterprise Ventures (General Partner NPIF YHTV Equity) Ltd 18,071,164 14.85%
Catenalucis LLC 7,788,488 6.40%
Thornapple LLP 6,113,124 5.02%
Touchstone Innovations Businesses LLP 4,164,756 3.42%

If you read below I was question from another posters point.
Relax friend and I do like HZM but it may not have bottomed.

You are comparing a £170m m/c company with a £5m m/c?
Of course HZM is better company, bigger board and better asset but can’t compare like for like and their share price isn’t doing great at the moment either.

What are the other juniors that are funded and bottomed out and don't have 'toxic' management?

Elephant Oil listing this week?

Understandable KimiR,
You sound knowledgeable and understand the markets.
Are you a buyer of RRR at 0.4…..despite AB?

What is the drama over Elephant Oil?
It was an investment by RRR which is now worth around $1.8-2m to RRR on the IPO. The IPO will be probably in the next two weeks whether they raise $7 or $10 or $15m.

I understand your point about $20 to $10m but that's sufficient funds for a serious campaign and you will know there is usually hype in the runup to drilling news in an oil company.

Even if the price were to fall the value for RRR as a business is very significant. It's a non-dilutive large raise to support the projects and plc costs. If the US market were to like the story and the share price were to rise it could be worth $3m+ every easily in a short period.

IMO RRR is a great buy at these levels with their projects and news flow to come. Including positive assay results from BF shortly which although may not be earth shattering but will still be positive and build on Kenya, Australia and the DRC.

If or when they manage to get the arbitration of $7.5m then RRR could go crazy with a squeeze on the stock at these levels. I see the positive at 0.35-0.5. GL.

'very, very soon'.... Heard this morning Spartan Capital have started marketing and raising capital for Elephant Oil and the IPO should be next week or latest second week in November. Not sure of the IPO price but have raised a substantial amount.

Helpful, can you confirm this to be true?

RRR benefit - IPO price range:
397,873 x $4.15 = $1,651,172
397,873 x $5.15 = $2,049,045

AB confirms he is still in the DRC…notice his first tweet on Copper in a while.

https://twitter.com/abell2019/status/1584519656605618177?s=46&t=vqWz1WPMH2mPG-jUunrd6A

Noticed the tick up with just 400k shares.
How much stock is available under 0.5?

In my opinion we've heard a couple of times from AB in StockBox interviews over the last couple of months that the arbitration has been won (stated the other side 'lost').

His last interview which is worth listening too states he's in the Congo until its 'finished'.
The other party needed to sign a paper which when that happens there will be a regulatory requirement to announce. AB's silence for once maybe a good thing rather than a bad one. Being in the Congo everything will be achieved and the longer it goes on the closer to news.

It is obviously how people perceive and past performance isn't great but if it is signed and RRR get that amount of non-dilutive money you won't see 0.4-0.5 again.

RRR also have assays to come from BF and an update on Elephant Oil which cannot be far away now and worth a couple of million US$ to the company.

https://twitter.com/StockBoxMedia/status/1578387305118695429?s=20&t=XmI1U6qwIffrPScZQ6juaw

It is also notable that any large sells under 0.4 are being bought very quickly and the share price moved to 0.6+ very easily last time AB was in the Congo. Just imagine what price it will be on a positive RNS.

Risk/Reward is in the Reward box for me, GL.

Elephant Oil is listing with or without AB and that’s the value of RRR’s shares at IPO this month.

Elephant Oil listing this month:

397,873 x $4.15 = $US 1,651,172.95
397,873 x $5.15 = $US 2,049,045.95

Hoping to rise on IPO and over the next 6 months - Red Rock is valued at £4-5m m/c and Andrew is in the DRC now getting the signature for $7.5m (hopefully)

Squeeze!